Mitochondria and dopamine: new insights into recessive parkinsonism
- PMID: 15294138
- DOI: 10.1016/j.neuron.2004.07.012
Mitochondria and dopamine: new insights into recessive parkinsonism
Abstract
Recessively inherited mutations in parkin, DJ-1, and PINK1 have recently been linked to familial forms of parkinsonism. These syndromes are often clinically indistinguishable from Parkinson's disease, as similar neuronal groups, notably dopaminergic neurons, are selectively affected. Studies of the functions of these gene products may provide insights into the pathogenic mechanisms underlying the selective degeneration of dopaminergic neurons. Emerging evidence that one or several of these genes play important roles in mitochondrial function and the dopaminergic system suggests that these events may be early steps of the pathophysiological changes of the disease. This review will summarize recent advances in our understanding of these gene products, with emphasis on the surprising convergence of their functions.
Copyright 2004 Cell Press
Similar articles
-
Mitochondrial injury: a hot spot for parkinsonism and Parkinson's disease?Sci Aging Knowledge Environ. 2004 Dec 1;2004(48):pe42. doi: 10.1126/sageke.2004.48.pe42. Sci Aging Knowledge Environ. 2004. PMID: 15576821 Review.
-
Autosomal recessive parkinsonism.Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S4-6. doi: 10.1016/S1353-8020(11)70004-9. Parkinsonism Relat Disord. 2012. PMID: 22166450 Review.
-
Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.Neurochem Int. 2008 May;52(6):1037-43. doi: 10.1016/j.neuint.2007.10.017. Epub 2007 Nov 4. Neurochem Int. 2008. PMID: 18069091
-
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.Eur J Hum Genet. 2005 Sep;13(9):1086-93. doi: 10.1038/sj.ejhg.5201455. Eur J Hum Genet. 2005. PMID: 15970950
-
Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.J Neurochem. 2009 Dec;111(5):1075-93. doi: 10.1111/j.1471-4159.2009.06403.x. Epub 2009 Sep 24. J Neurochem. 2009. PMID: 19780902 Review.
Cited by
-
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.J Neurosci. 2007 Nov 7;27(45):12413-8. doi: 10.1523/JNEUROSCI.0719-07.2007. J Neurosci. 2007. PMID: 17989306 Free PMC article.
-
Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.J Negat Results Biomed. 2005 Dec 14;4:10. doi: 10.1186/1477-5751-4-10. J Negat Results Biomed. 2005. PMID: 16354302 Free PMC article.
-
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11364-9. doi: 10.1073/pnas.0802076105. Epub 2008 Aug 7. Proc Natl Acad Sci U S A. 2008. PMID: 18687901 Free PMC article.
-
PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway.Oncotarget. 2017 Sep 15;8(45):79046-79060. doi: 10.18632/oncotarget.20893. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108286 Free PMC article.
-
A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway.Cell Transplant. 2017 Sep;26(9):1560-1571. doi: 10.1177/0963689717721234. Cell Transplant. 2017. PMID: 29113464 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources